Ge Mang Selected Research

Myocarditis (Carditis)

10/2020	Corrigendum to "Protosappanin A protects against experimental autoimmune myocarditis, and induces metabolically reprogrammed tolerogenic DCs" (Pharmacol. Res. 146 (2019) 104269).
1/2019	Protosappanin A protects against experimental autoimmune myocarditis, and induces metabolically reprogrammed tolerogenic DCs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ge Mang Research Topics

Disease

2	Myocardial Infarction 11/2022 - 01/2022
2	Myocarditis (Carditis) 10/2020 - 01/2019
1	Venous Thrombosis (Deep-Vein Thrombosis) 03/2024
1	Thrombosis (Thrombus) 01/2024
1	Brain Injuries (Brain Injury) 01/2024
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2023
1	Hematoma 11/2022
1	Hypoxia (Hypoxemia) 01/2022

Drug/Important Bio-Agent (IBA)

2	Deoxyribonuclease I (Nickase)IBA 01/2023 - 11/2022
2	Histones (Histone)IBA 11/2022 - 11/2022
2	protosappanin AIBA 10/2020 - 01/2019
1	Platelet Factor 4IBA 03/2024
1	HMGB1 Protein (HMG1)IBA 01/2024
1	DNA (Deoxyribonucleic Acid)IBA 11/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	MethyltransferasesIBA 01/2022